However, there were no differences in the levels of cell surface expression of RANKL (or RANKL mRNA expression in whole BM extracts) on CD45- or B lineage cells amongst any of the groups during the established phase of joint disease (results not shown). This evidence concerns the gene PTPRC and arthropathy.